Delivery Order HHSN272201600008I-HHSN27200007
Award Date
6/29/17
Potential Completion Date
6/30/24
Potential Value
$9.2M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for the final transition and continued operation of a non-human primate (NHP) breeding colony. The contract, valued at $2,252,481.00, is a Delivery Order issued under the Simian Vaccine Evaluation Units 2013-2020 master IDIQ contract. ABL, a for-profit organization...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, titled "SIMIAN VACCINE EVALUATION UNITS," was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization specializing in the development of vaccines, biologics, and other medical countermeasures. The...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $3,780,242.42, is for the provision of Simian Vaccine Evaluation Units, which involves the development of vaccines and other medical countermeasures for infectious diseases. The...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $964,411.81, is for the Simian Vaccine Evaluation Units program, which supports the development of vaccines and countermeasures for infectious diseases. The contract does...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The contract is for the Simian Vaccine Evaluation Units program and has a ceiling value of $1,510,348.00. The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract for Simian Vaccine Evaluation Units between 2013-2020. The contract is a Cost...
This federal contract award, valued at $462,454.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer. The contract is a Delivery Order under the Simian Vaccine Evaluation Units 2013-2020 Indefinite Delivery Vehicle (IDV), and the work involves providing administrative and technical support for ongoing Task Area 3 studies and final transition. The contract does not have...
This federal contract award, valued at $1,469,410.09, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods and a leading contract research and manufacturing organization specializing in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract is for NIAID...
This federal contract award of $9,360,216.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract supports NIAID's Preclinical Development program for the production of Current Good Manufacturing Practice (cGMP) native flexibly linked HIV-1 envelope protein. ABL has been awarded multiple Indefinite...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued at $1,826,332.06, is for the provision of preclinical development support services related to the NIAID's infectious disease research and product development...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $9,967,500.00 cost-plus-fixed-fee contract supports NIAID's Preclinical Development program, specifically the production of the MHRP GP145 Clade C trimer protein. This contract does not have a set-aside designation. ABL, a for-profit manufacturer of goods, has been...